Carsten Denkert Selected Research

Carsten Denkert Research Topics

Disease

194	Neoplasms (Cancer) 04/2024 - 03/2002
164	Breast Neoplasms (Breast Cancer) 04/2024 - 06/2003
55	Carcinoma (Carcinomatosis) 02/2024 - 03/2002
37	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 10/2002
36	Triple Negative Breast Neoplasms 04/2024 - 01/2013
19	Pathologic Complete Response 11/2023 - 05/2012
13	Neoplasm Metastasis (Metastasis) 11/2023 - 11/2007
12	Adenocarcinoma 11/2023 - 01/2003
8	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2003
7	Carcinogenesis 01/2021 - 06/2005
6	Ovarian Epithelial Carcinoma 01/2023 - 11/2007
5	Colonic Neoplasms (Colon Cancer) 01/2023 - 09/2005
4	Residual Neoplasm 09/2022 - 06/2009
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2016 - 01/2005
3	Lymphatic Metastasis 02/2024 - 04/2006
3	Neuroendocrine Carcinoma 02/2024 - 10/2021
3	Inflammation (Inflammations) 10/2022 - 02/2004
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 09/2005
3	Disease Progression 01/2020 - 04/2005
3	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2019 - 04/2012
3	Melanoma (Melanoma, Malignant) 11/2017 - 01/2002
3	Stomach Neoplasms (Stomach Cancer) 05/2012 - 04/2006
3	Prostatic Neoplasms (Prostate Cancer) 02/2008 - 08/2004
3	Adenoma (Adenomas) 02/2005 - 06/2002

Drug/Important Bio-Agent (IBA)

54	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2005
52	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2002
38	Estrogen ReceptorsIBA 04/2024 - 06/2003
35	Hormones (Hormone)IBA 04/2024 - 01/2009
34	Messenger RNA (mRNA)IBA 10/2022 - 03/2002
22	ParaffinIBA 07/2020 - 06/2002
21	taxaneIBA 10/2021 - 01/2007
19	human ERBB2 proteinIBA 01/2023 - 01/2009
18	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 04/2006
18	Formaldehyde (Formol)FDA Link 07/2020 - 09/2003
17	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 04/2006
15	AnthracyclinesIBA 07/2020 - 01/2009
14	Phenobarbital (Luminal)FDA Link 12/2023 - 11/2010
14	Immune Checkpoint InhibitorsIBA 01/2023 - 03/2016
13	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 06/2014
13	Trastuzumab (Herceptin)FDA Link 01/2023 - 07/2011
13	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 01/2012
13	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2002
11	130-nm albumin-bound paclitaxelIBA 11/2023 - 10/2015
11	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2009 - 03/2002
10	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2010
10	Progesterone Receptors (Progesterone Receptor)IBA 02/2023 - 01/2009
10	Protein Isoforms (Isoforms)IBA 04/2022 - 06/2003
10	PlatinumIBA 11/2021 - 01/2007
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2009
8	LipidsIBA 05/2021 - 09/2008
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 06/2011
7	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 04/2006
6	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2012
5	Phosphotransferases (Kinase)IBA 04/2024 - 01/2002
5	Epidermal Growth Factor (EGF)IBA 12/2023 - 02/2017
5	LigandsIBA 11/2023 - 09/2014
5	Gemcitabine FDA Link 01/2021 - 08/2016
5	Carrier Proteins (Binding Protein)IBA 10/2020 - 05/2009
5	Histone Deacetylases (Histone Deacetylase)IBA 04/2013 - 02/2008
5	Histone Deacetylase InhibitorsIBA 11/2009 - 02/2008
5	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2007 - 06/2003
4	Poly Adenosine Diphosphate RiboseIBA 04/2024 - 06/2011
4	ElementsIBA 02/2024 - 11/2015
4	Eosine Yellowish-(YS) (Eosin)IBA 02/2024 - 09/2017
4	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 01/2021
4	EnzymesIBA 10/2023 - 03/2002
4	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 04/2006
4	B7-H1 AntigenIBA 12/2021 - 01/2016
4	MicroRNAs (MicroRNA)IBA 10/2018 - 02/2010
4	Glutamine (L-Glutamine)FDA Link 01/2016 - 11/2012
4	ELAV-Like Protein 1IBA 02/2008 - 01/2004
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2006 - 03/2002
4	Polo-Like Kinase 1IBA 04/2006 - 08/2004
3	durvalumabIBA 04/2024 - 01/2021
3	Hematoxylin (Haematoxylon)IBA 02/2024 - 09/2017
3	Transcription Factors (Transcription Factor)IBA 02/2024 - 10/2020
3	Denosumab FDA Link 11/2023 - 01/2022
3	SynaptophysinIBA 11/2023 - 10/2021
3	pembrolizumabIBA 11/2023 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022 - 01/2012
3	liposomal doxorubicin (Doxil)FDA Link 01/2022 - 01/2019
3	CytokinesIBA 01/2022 - 01/2002
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 05/2003
3	Estrogens (Estrogen)FDA Link 01/2021 - 12/2009
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2020 - 10/2014
3	Androgen Receptors (Androgen Receptor)IBA 02/2020 - 11/2011
3	Indicators and Reagents (Reagents)IBA 04/2017 - 02/2008
3	InterferonsIBA 01/2017 - 01/2013
3	Glutamic Acid (Glutamate)FDA Link 01/2016 - 12/2013
3	Fluorouracil (Carac)FDA LinkGeneric 10/2015 - 04/2006
3	Docetaxel (Taxotere)FDA Link 08/2013 - 11/2011
3	leptomycin BIBA 07/2011 - 02/2008
3	ProstaglandinsIBA 02/2004 - 03/2002

Therapy/Procedure

97	Therapeutics 04/2024 - 05/2003
75	Neoadjuvant Therapy 02/2024 - 01/2009
56	Drug Therapy (Chemotherapy) 12/2023 - 01/2005
12	Immunotherapy 04/2022 - 01/2013
7	Adjuvant Chemotherapy 01/2021 - 12/2009
5	Aftercare (After-Treatment) 11/2018 - 02/2005
3	Radiotherapy 02/2024 - 11/2019